Point72 Hong Kong LTD Sigilon Therapeutics, Inc. Transaction History

Point72 Hong Kong LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$2.58 - $6.13 $1,643 - $3,904	-637 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$4.42 - $10.61 $2,815 - $6,758	637 New	637 $4,000
Q1 2021 May 17, 2021	SELL	$18.76 - $40.91 $78,416 - $171,003	-4,180 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$27.6 - $48.03 $115,368 - $200,765	4,180 New	4,180 $201,000

Ticker SGTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 32,399,300
Description
Sigilon Therapeutics, Inc., a clinical stage biotechnology company, develops functional cures for patients with chronic diseases. Its lead product candidate is SIG-001, which is in Phase I/II clinical trial to prevent bleeding episodes in patients with moderate to severe Hemophilia A. The company is also developing SIG-005 to treat the non-neuro...

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

Stay updated on Point72 Hong Kong LTD with notifications on news.